Vaxxas Inc

Website
47 Thorndike St Ste B1-1
Cambridge, MA 02141
https://www.vaxxas.com

Vaxxas Inc, based in Cambridge, MA, is pioneering a novel vaccination technology designed to enhance the efficacy of both existing and next-generation vaccines. Their innovative HD-MAP technology utilizes a needle-free patch that delivers vaccines through thousands of micro-projections, targeting the abundant immune cells just beneath the skin's surface.

Committed to transforming the value paradigm of vaccines, Vaxxas has successfully productized its HD-MAP platform for commercial use, validated through human clinical studies and designed for large-scale manufacturing. The company collaborates with renowned organizations to maximize the global impact of its groundbreaking technology.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Enzyvant Therapeutics Inc

Enzyvant Therapeutics Inc, based in Cambridge, MA, is a pioneering company dedicated to improving global health and well-being. With a focus on critical areas such as psychiatry, neurology, oncology, urology, women's health, rare diseases, and cell gene therapy, they drive innovation in treatments, science, and technology to address patient needs. Enzyvant's diverse pipeline of preclinical and clinical programs spans various modalities and indications, aiming to meet high or unmet patient needs. Through their technology-driven approach, they strive to deliver breakthrough solutions that prioritize patient outcomes, making a measurable impact on healthcare.Generated from the website

BeiGene USA, Inc

BeiGene USA, Inc, based in Cambridge, is a biopharmaceutical company dedicated to developing innovative drug candidates targeting cancer through molecular and immuno-oncology approaches. The company's primary focus is on advancing therapies that have the potential to transform the treatment landscape for cancer patients, with a commitment to improving outcomes and quality of life. Generated from their website's infomation

Sage Therapeutics, Inc

Sage Therapeutics, Inc., based in Cambridge, MA, is focused on rethinking the delivery of care for patients and families affected by brain health disorders. Through innovative research programs and a commitment to patient advocacy, the company aims to transform the understanding and treatment of neurological conditions. In collaboration with partners like Shionogi Co. Ltd., Sage is advancing its clinical pipeline, including investigational treatments such as zuranolone. The company emphasizes safety and efficacy in its research, continually striving to improve outcomes for those impacted by brain health issues. Generated from the website
United States›Massachusetts›Cambridge›Vaxxas Inc

Partial Data by Infogroup (c) 2025. All rights reserved.